Colliers Securities analyst Eugene Mannheimer reiterated a Buy rating on R1 RCM (NASDAQ:RCM) Inc on Friday, setting a price target of $34, which is approximately 34.81% above the present share price of $25.22.
Mannheimer expects R1 RCM Inc to post earnings per share (EPS) of $0.31 for the first quarter of 2021.
The current consensus among 6 TipRanks analysts is for a Strong Buy rating of shares in R1 RCM, with an average price target of $35.17.
The analysts price targets range from a high of $37 to a low of $34.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $328.4 million and a net profit of $36.8 million. The company's market cap is $6.58 billion.
According to TipRanks.com, Colliers Securities analyst Eugene Mannheimer is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 16.1% and a 60.26% success rate.
R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Chicago, IL.